scholarly journals Pain Correlates of Depressed Mood

1998 ◽  
Vol 3 (3) ◽  
pp. 135-144 ◽  
Author(s):  
Trudi M Walsh ◽  
Chloé P Smith ◽  
Patrick J McGrath
Keyword(s):  
Young Adults ◽  
Sleep Disturbance ◽  
Pain Intensity ◽  
Depressed Mood ◽  
Pain Catastrophizing ◽  
Short Form ◽  
Mcgill Pain Questionnaire ◽  
Testing Time ◽  
Low Levels ◽  
Underlying Mechanisms

OBJECTIVE: To provide an initial indication of the intensity and quality of pain in young adults reporting depressed mood and to investigate possible underlying mechanisms.DESIGN: Case-control study.SETTING: University undergraduate subject pool.PARTICIPANTS: Sixty introductory psychology undergraduates classified as either reporting high levels of depressed mood (n=30; age 18.7±0.87 years, mean ± SD) or reporting low levels of depressed mood (n=30; age 18.6±0.81 years).MAIN OUTCOME MEASURES: Beck Depression Inventory, Short-Form McGill Pain Questionnaire, Pain Catastrophizing Scale, Pittsburgh Sleep Quality Index and pressure dolorimeter pain thresholds.RESULTS: Young adults reporting high levels of depressed mood had significantly higher pain intensity at testing time, as measured by a visual analogue scale (P=0.015) and a present pain index (P=0.002), affective pain intensity for the previous month (P=0.000), pain catastrophizing (P=0.025) and global sleep disturbance (P=0.000) than young adults reporting low levels of depressed mood. Within the group of young adults reporting high levels of depressed mood, significantly higher sleep disturbance scores (P=0.020) were identified in those reporting high levels of overall pain intensity.CONCLUSIONS: The results are discussed in terms of their implications for research as well as for the assessment and treatment of pain in individuals with depression.

scholarly journals Comparative Analysis of Periodontal Pain According to the Type of Precision Orthodontic Appliances: Vestibular, Lingual and Aligners. A Prospective Clinical Study

Biology ◽  
2021 ◽  
Vol 10 (5) ◽  
pp. 379
Author(s):  
Laura Antonio-Zancajo ◽  
Javier Montero ◽  
Daniele Garcovich ◽  
Mario Alvarado-Lorenzo ◽  
Alberto Albaladejo ◽  
...  
Keyword(s):  
Clinical Study ◽  
Pain Intensity ◽  
Short Form ◽  
Study Groups ◽  
Mcgill Pain Questionnaire ◽  
Prospective Clinical Study ◽  
Orthodontic Appliances ◽  
Low Friction ◽  
Different Types ◽  
Lower Arch

The objective of this prospective clinical study was to analyze the pain (intensity, location and type) that patients presented after the placement of different types of orthodontic appliances: conventional, low friction, lingual and aligners. The sample consisted of 120 patients divided into four groups: conventional (CON), low friction (LF), lingual (LO) and aligners (INV). The participants were given the Short-Form McGill Pain Questionnaire (Ortho-SF-MPQ), where they had to record the pain intensity (no pain, mild, moderate or intense) and the periodontal location at different time points, from the first 4 h to 7 days after the start of treatment. In all the study groups, the most frequent location was both anterior arches, with maximum values between 56.7% (CON group at 24 h) and 30% (LO group at 4 h). The “whole mouth” and “complete lower arch” locations were indicated only by the patients in the lingual group. Regarding pain intensity, the patients reported a higher percentage of mild–moderate pain during the first 3 days of treatment (96.7% in LO at 4 h, 86.7% in CON, 83.3% in LF and 90% in INV at 24 h); later, the reported pain decreased to no pain/mild pain, especially in the lingual group, until reaching values close to zero at 7 days post-treatment. The most frequent type of pain was acute in the low friction and lingual groups (with maxima of 60% and 46.7% at 24 h, respectively). On the contrary, in the conventional (36.7% at 4 h) and Invisalign (40% at 24 h) groups, the sensitive type was the most frequent. There are differences regarding periodontal pain in its intensity, location and type according to the use of different orthodontic techniques.

scholarly journals PainVision® Apparatus for Assessment of Efficacy of Pulsed Radiofrequency Combined with Pharmacological Therapy in the Treatment of Postherpetic Neuralgia and Correlations with Measurements

2017 ◽  
Vol 2017 ◽  
pp. 1-8 ◽  
Author(s):  
Dong Wang ◽  
Kai Zhang ◽  
ShaoLong Han ◽  
LingZhi Yu
Keyword(s):  
Pain Intensity ◽  
Postherpetic Neuralgia ◽  
Breakthrough Pain ◽  
Short Form ◽  
Persistent Pain ◽  
Pharmacological Therapy ◽  
Control Group ◽  
Mcgill Pain Questionnaire ◽  
Pulsed Radiofrequency ◽  
Highly Correlated

Objective. PainVision device was a developed application for the evaluation of pain intensity. The objective was to assess the efficacy and safety of pulsed radiofrequency (PRF) combined with pharmacological therapy in the treatment of postherpetic neuralgia (PHN). We also discussed the correlation of the measurements.Method. Forty patients with PHN were randomized for treatment with PRF combined with pharmacological therapy (PRF group,n=20) or pharmacological therapy (control group,n=20) at postoperative 48 hours. The efficacy measure was pain degree (PD) that was assessed by PainVision and visual analog scale (VAS), short form Mcgill pain questionnaire (SF-Mcgill), and numeric rate scale sleep interference score (NRSSIS). Correlations between PD, VAS, SF-Mcgill, and NRSSIS were determined.Results. The PD for persistent pain (PP) and breakthrough pain (BTP) at postoperative 48 hours assessed by PainVision were significantly lower in PRF group than in control group (PD-PP,P<0.01; PD-BTP,P<0.01). PD and VAS were highly correlated for both persistent pain (r=0.453,ρ=0.008) and breakthrough pain (r=0.64,ρ=0.001).Conclusion. PRF was well tolerated and superior to isolated pharmacological therapy in the treatment of PHN. PainVision device showed great value in the evaluation of pain intensity and PD had an excellent correlation with VAS and SF-Mcgill.

scholarly journals Central Sensitivity Is Associated with Poor Recovery of Pain: Prediction, Cluster, and Decision Tree Analyses

2020 ◽  
Vol 2020 ◽  
pp. 1-12
Author(s):  
Hayato Shigetoh ◽  
Masayuki Koga ◽  
Yoichi Tanaka ◽  
Shu Morioka
Keyword(s):  
Cluster Analysis ◽  
Decision Tree ◽  
Pain Intensity ◽  
Outcome Measures ◽  
Short Form ◽  
Depression Scale ◽  
Hierarchical Cluster ◽  
Mcgill Pain Questionnaire ◽  
Decision Tree Analysis ◽  
Tree Analysis

The process of pain recovery varies and can include the recovery, maintenance, or worsening of symptoms. Many cases of patients with pain show a tendency of recovering as predicted; however, some do not. The characteristics of cases that do not fit the prediction of pain recovery remain unclear. We performed cluster and decision tree analyses to reveal the characteristics in cases that do not fit the prediction of pain recovery. A total of 43 patients with musculoskeletal pain (nonoperative: 22 patients, operative: 13 patients) and central pain (brain disease: 5 patients, spinal cord disease: 3 patients) were included in this longitudinal study. Central sensitivity syndrome (CSS) outcome measures (Central Sensitisation Inventory), pain intensity-related outcome measures (Short-Form McGill Pain Questionnaire-2 (SFMPQ-2)), and cognitive-emotional outcome measures (Hospital Anxiety and Depression Scale and Pain Catastrophising Scale-4) of all patients were assessed at baseline and after 1-2 months. Regression analysis was used to calculate pain recovery prediction values. A hierarchical cluster analysis based on the predicted change of SFMPQ-2 and the observed change of SFMPQ-2 was used to extract subgroups that fit and those that do not fit pain recovery prediction. To extract the characteristics of subgroups that do not fit the prediction of pain recovery, a decision tree analysis was performed. The level of significance was set at 5%. In the results of cluster analysis, patients were classified into three subgroups. Cluster 1 was characterised by worse pain intensity from baseline, cluster 2 by pain, having recovered less and mildly than the predicted value, and Cluster 3 by a marked recovery of pain. In the results of the decision tree analysis, the CSI change was extracted as an indicator related to the classification of all clusters. Our findings suggest that the poor improvement of CSS is characteristic in cases that do not fit the prediction of pain recovery.

scholarly journals Pain is a common problem in patients with ILD

2020 ◽  
Author(s):  
Qinxue Shen ◽  
Ting Guo ◽  
Min Song ◽  
Wei Guo ◽  
Yi Zhang ◽  
...  
Keyword(s):  
Pain Intensity ◽  
Short Form ◽  
Depression Scale ◽  
Brief Pain Inventory ◽  
Mcgill Pain Questionnaire ◽  
Sf 36 ◽  
Related Quality ◽  
Health Related ◽  
History Of ◽  
Exposure History

Abstract Background: As it is less known about the prevalence and characteristics of pain in the patients with interstitial lung disease (ILD), this paper aims at determining the characteristics of the pain in the patients with ILD.Methods: Subjects with ILD and health controls with the matched ages and genders completed Short Form McGill Pain Questionnaire (SF-MPQ) and part of the Brief Pain Inventory (BPI) Short Form to elicit the characteristics of the pain. The patients with ILD were also assessed through Pulmonary Function Test, Six Minutes Walking Test (6MWT), modified Medical Research Council Dyspnea Scale (mMRC) for state of the illness and measured health-related quality of life (HRQoL) by Short Form-36 (SF-36) and psychological associations by Hospital Anxiety and Depression Scale (HADS).Results: A total of 63 subjects with ILD and 63 healthy controls (HC) were recruited in our study. The prevalence of the pain was 61.9% in ILD versus 25.3% in HC (p=0.005) and the median score of the pain rank index (PRI) in ILD was higher than that in HC (P=0.014). Chest (46.1%) accounted for the highest of overall pain locations in subjects with ILD. Associated clinical factors for pain intensity in the patients with ILD included exposure history of risk factors of ILD, with a longer distance of 6MWD (≥250m), and a higher mMRC score (2-4). The patients with ILD and pain are more likely to suffer impaired HRQoL (P=0.0014) and psychological problems (P=0.0017, P=0.044).Conclusion: The pain is common in those with ILD and the pain intensity is associated with exposure history, 6MWD, and mMRC score. The patients with ILD and pain were possibly to suffer depression, anxiety, and impaired HRQoL.

scholarly journals Pain is a common problem in patients with ILD

2020 ◽  
Author(s):  
Qinxue Shen ◽  
Ting Guo ◽  
Min Song ◽  
Wei Guo ◽  
Yi Zhang ◽  
...  
Keyword(s):  
Pain Intensity ◽  
Short Form ◽  
Depression Scale ◽  
Brief Pain Inventory ◽  
Mcgill Pain Questionnaire ◽  
Healthy Controls ◽  
Related Quality ◽  
Health Related ◽  
History Of ◽  
Exposure History

Abstract Background Less is known about the prevalence and characteristics of pain in interstitial lung disease (ILD) patients.To determine the characteristics of pain in ILD patients. Methods Participants with ILD and age, gender-matched, healthy controls completed short form McGill Pain Questionnaire (SF-MPQ) and part of the Brief Pain Inventory short form(BPI) to elicit pain characteristics. ILD patients also had assessments of pulmonary function test, six minutes walking test (6MWT), modified medical research council dyspnea scale (mMRC) for state of the illness and measured health-related quality of life(HRQoL) by short form-36(SF-36)and psychological associations by hospital anxiety and depression scale(HADS). Results A total of 63 participants with ILD and 63 healthy controls(HC) were recruited in our study. The prevalence of pain was 61.9% in ILDs versus 25.3% in HC (p=0.005) and the median score of pain rank index (PRI) in ILDs was higher than in HC (P=0.014). Chest(46.1%) accounted for the highest of overall pain locations in participants with ILD. Associated clinical factors for pain intensity in ILD patients included younger age (<60 years), exposure history of ILD risk factors, longer distance of 6MWD(≥250m), higher mMRC score(2-4) and lower DLCo, % predicted(≤45%). ILD patients with pain are more likely to suffer impaired HRQoL(P=0.0014) and psychological problems(P=0.0017,P=0.044). Conclusion Pain is common in those with ILD and the pain intensity is associated with age, exposure history, 6MWD, mMRC score and DLCo, % predicted. ILD patients with pain have more possible to suffer depression, anxiety and impaired HRQoL.

Predictors of the Pain Perception and Self-Efficacy for Pain Control in Patients with Fibromyalgia

2011 ◽  
Vol 14 (1) ◽  
pp. 366-373 ◽  
Author(s):  
Ana I. Sánchez ◽  
M. Pilar Martínez ◽  
Elena Miró ◽  
Ana Medina
Keyword(s):  
Self Efficacy ◽  
Pain Perception ◽  
Pain Catastrophizing ◽  
Short Form ◽  
Depression Scale ◽  
The Self ◽  
Mcgill Pain Questionnaire ◽  
Efficacy Expectations ◽  
And Coping ◽  
Pain Anxiety Symptoms Scale

Objective: This study analyzes the role of a number of cognitive-affective dimensions in the experience and coping of pain in patients with fibromyalgia (FM). Specifically, it was examined whether anxiety, depression, pain catastrophizing and pain-related anxiety predict the pain perception and the self-efficacy expectations in these patients.Method: Seventy-four fibromyalgia patients were asked to complete a questionnaire survey including theChronic Pain Self-Efficacy Scale, theHospital Anxiety and Depression Scale, thePain Anxiety Symptoms Scale-20, thePain Catastrophizing Scale, and theShort-form McGill Pain Questionnaire. Results: Some relevant correlation and predicting patterns were identified. Physiological anxiety was the best predictor of the sensorial dimension of pain. Pain fear was a significant predictor of the pain intensity. Helplessness was the best predictor of the affective dimension of pain, whereas depression was a significant predicting variable of the self-efficacy expectations.Conclusions: This study shows the relevance of the pain-related anxiety in the pain perception, and of the depression in the self-efficacy expectations in FM patients. Clinical applications of the findings and further research lines in this area are discussed.

scholarly journals Chronic Pain Assessment: A Seven-Factor Model

2008 ◽  
Vol 13 (4) ◽  
pp. 299-308 ◽  
Author(s):  
Megan A Davidson ◽  
Dean A Tripp ◽  
Leandre R Fabrigar ◽  
Paul R Davidson
Keyword(s):  
Chronic Pain ◽  
Coping Strategies ◽  
Factor Model ◽  
Pain Catastrophizing ◽  
Short Form ◽  
Activity Level ◽  
Mcgill Pain Questionnaire ◽  
Pain Coping ◽  
Pain Experience ◽  
The Core

BACKGROUND: There are many measures assessing related dimensions of the chronic pain experience (eg, pain severity, pain coping, depression, activity level), but the relationships among them have not been systematically established.OBJECTIVE: The present study set out to determine the core dimensions requiring assessment in individuals with chronic pain.METHODS: Individuals with chronic pain (n=126) completed the Beck Anxiety Inventory, Beck Depression Inventory, Beck Hopelessness Scale, Chronic Pain Coping Index, Multidimensional Pain Inventory, Pain Catastrophizing Scale, McGill Pain Questionnaire – Short Form, Pain Disability Index and the Tampa Scale of Kinesiophobia.RESULTS: Before an exploratory factor analysis (EFA) of the nine chronic pain measures, EFAs were conducted on each of the individual measures, and the derived factors (subscales) from each measure were submitted together for a single EFA. A seven-factor model best fit the data, representing the core factors of pain and disability, pain description, affective distress, support, positive coping strategies, negative coping strategies and activity.CONCLUSIONS: Seven meaningful dimensions of the pain experience were reliably and systematically extracted. Implications and future directions for this work are discussed.

scholarly journals FRI0567 CONSTRUCT VALIDATION OF PROMIS SHORT FORM AND PROFILE-29 T-SCORES WITH SF-36 IN RHEUMATOID ARTHRITIS PATIENTS TREATED FOR 1 YEAR: RESULTS FROM A REAL‑WORLD EVIDENCE-BASED STUDY IN THE UNITED STATES

2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 886.2-886
Author(s):  
C. Bingham ◽  
S. Kafka ◽  
S. Black ◽  
S. Xu ◽  
W. Langholff ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Clinical Practice ◽  
Disease Activity ◽  
Sleep Disturbance ◽  
Pain Intensity ◽  
Real World ◽  
Short Form ◽  
Research Support ◽  
Sf 36 ◽  
Component Scores

Background:Use of patient-reported outcomes (PROs) to assess health-related quality of life in clinical practice, research studies, and clinical trials in rheumatoid arthritis (RA) remains an ongoing area of research. SF-36 is commonly used in RA trials but is not feasible for routine use in clinical practice settings. ThePatientReportedOutcomesMeasurementInformationSystem (PROMIS) may address this gap but has not been widely assessed in RA patients starting therapy in a real-world comparative effectiveness study, nor examined in that setting in relation to the SF36 and Clinical Disease Activity Index (CDAI).Objectives:To assess validity of PROMIS based on Comparative and Pragmatic Study of Golimumab Intravenous (IV) Versus Infliximab in Rheumatoid Arthritis (AWARE), an ongoing Phase 4 study providing real-world assessment of IV tumor necrosis factor inhibitor (TNFi) medications in RA patients.Methods:AWARE is a prospective, non-interventional, 3-year study conducted at 88 US sites. RA patients were enrolled when initiating TNFi treatment. Treatment decisions were made by treating rheumatologists. We report baseline PROMIS-29 (7 domains and pain intensity), PROMIS Pain Interference (PI) Short Form (SF) 6b (PI6b) and PROMIS Fatigue (F) Short Form 7a (F7a), domain T-Scores, and SF-36 subdomain and Component Scores (CS) in AWARE patients. Here we report baseline data obtained from the final 1-year AWARE dataset. Correlations between PROMIS measures and comparable SF-36 component scores were calculated using Pearson correlations. Data is shown as mean ± standard deviation (SD).Results:At baseline, mean CDAI of all patients (n=1262) was 32.3±15.6, with 70.4% in high disease activity (HDA, CDAI>22), 22.8% in moderate disease activity (MDA, CDAI: >10 and ≤22), 6.1% in low disease activity (LDA, CDAI: >2.8 and ≤10), and 0.7% in remission (CDAI ≤2.8). Mean PROMIS scores were >0.5 SD worse than population means for Physical Function (PF, 38.1±6.84), PI (63.4±7.68), F (58.8±9.95), Sleep Disturbance (55.1±8.68); and Ability to Participate in Social Roles/Activities (PSRA, 43.4±8.58). Baseline Depression and Anxiety were within 0.5 SD of population T-scores. PI6b, F7a, and P29 domain T-scores correlated with the comparable SF-36 subdomain and component scores (r’s >0.58), except sleep for which no comparable SF-36 element was applicable. Examples include: P6b (r=-0.80) and P29-PI (0.81) with SF-36 Bodily Pain; F7a (-0.77) and P29-F (-0.77) with SF-36 Vitality; P29-PF with SF-36 PF (0.77), Role-Physical (0.69), and Physical CS (0.73); P29 Anxiety with SF-36 Mental Health (-0.72), Role-Emotional (-0.56), Mental CS (-0.70); and P29-PRSA with SF-36-Social Functioning (0.71). Mean PROMIS-29 T-scores (except Anxiety and Sleep Disturbance) among patients with HDA were significantly different from patients with MDA, LDA or remission (p < 0.001 for all). Further, mean PROMIS T-scores of PF, F, PSRA, PI, Pain Intensity, PI6b and P7a among patients with MDA were significantly different from patients with more or less active RA (by CDAI category).Conclusion:Analysis of baseline results from a large cohort of RA patients indicates high correlations between individual P29 domain T-scores and SF-36 component scores, as well as categorical CDAI, providing strong evidence of PROMIS construct validity in a real-world population of RA patients.Disclosure of Interests:Clifton Bingham Grant/research support from: Bristol-Myers Squibb, Consultant of: Bristol-Myers Squibb, Shelly Kafka Employee of: Janssen Scientific Affairs, LLC, Shawn Black Employee of: Janssen Research & Development, LLC, Janssen Scientific Affairs, LLC, Stephen Xu Employee of: Janssen Research & Development, LLC, Wayne Langholff Employee of: Janssen Research & Development, LLC, Jeffrey Curtis Grant/research support from: AbbVie, Amgen, Bristol-Myers Squibb, Corrona, Janssen, Lilly, Myriad, Pfizer, Regeneron, Roche, UCB, Consultant of: AbbVie, Amgen, Bristol-Myers Squibb, Corrona, Janssen, Lilly, Myriad, Pfizer, Regeneron, Roche, UCB

scholarly journals Migraine Disability, Pain Catastrophizing, And Headache Severity Are Associated With Evoked Pain And Targeted By Mind-Body Therapy

2021 ◽  
Author(s):  
Samuel R Krimmel ◽  
Michael L Keaser ◽  
Darrah R Speis ◽  
Jennifer A Haythornthwaite ◽  
David A Seminowicz
Keyword(s):  
Sleep Disturbances ◽  
Pain Catastrophizing ◽  
Short Form ◽  
Brief Pain Inventory ◽  
Small Sample ◽  
Mcgill Pain Questionnaire ◽  
Headache Frequency ◽  
Healthy Controls ◽  
Pain Ratings ◽  
Body Therapy

Meta-analysis suggests migraine patients are no more sensitive to experimentally evoked pain than healthy controls. At the same time, studies have linked some migraine symptoms to Quantitative Sensory Testing (QST) profiles. Unfortunately, previous studies associating migraine symptoms and QST have important methodological shortcomings, stemming from inappropriate statistics, small sample sizes, and frequent use of univariate statistics for multivariate research questions. In the current study we seek to address these limitations by using a large sample of episodic migraine patients (n=103) and a multivariate analysis that associates pain ratings from many thermal intensities simultaneously with 12 clinical measures ranging from headache frequency to sleep abnormalities. We identified a single dimension of association between QST and migraine symptoms that relates to pain ratings for all stimulus intensities and a subset of migraine symptoms relating to disability (Headache Impact Trauma 6 and Brief Pain Inventory interference), catastrophizing (Pain Catastrophizing Scale), and pain severity (average headache pain, Brief Pain Inventory severity, and Short Form McGill Pain Questionnaire 2). Headache frequency, allodynia, affect, and sleep disturbances were unrelated to this dimension. Consistent with previous research, we did not observe any difference in QST ratings between migraine patients and healthy controls. Additionally, we found that the linear combination of symptoms that related to QST were modified by mind-body therapy. These results suggest that QST has a selective relationship with pain symptoms even in the absence of between-subjects differences between chronic pain patients and healthy controls.

Adult Patients' Postoperative Pain Descriptions and Responses to the Short-Form McGill Pain Questionnaire

2001 ◽  
Vol 10 (4) ◽  
pp. 442-452 ◽  
Author(s):  
Deborah Dillon McDonald ◽  
Constance Spagnola Weiskopf
Keyword(s):  
Postoperative Pain ◽  
Pain Intensity ◽  
Clinical Relevance ◽  
Short Form ◽  
Adult Patients ◽  
Clinical Usefulness ◽  
Mcgill Pain Questionnaire ◽  
Precise Information ◽  
Pain Questionnaire

This study examined the clinical usefulness of the Short-Form McGill Pain Questionnaire (SF-MPQ). Thirty postoperative patients were asked to describe their postoperative pain and then administered the SF-MPQ. Eighteen (60%) used exact SF-MPQ sensory or affective words or synonyms to describe their postoperative pain during the interview. These results provide further evidence of the clinical relevance of the SF-MPQ sensory and affective scales. Pain descriptions by patients that go beyond pain intensity descriptions may communicate more precise information about the pain and lead to more effective pain interventions. Patients with difficulty describing their pain might be assisted by using the SF-MPQ.

Sign in / Sign up

Export Citation Format

Share Document